The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 1,544 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | Sponsored ADR | 04351P101 | 1,624 | 13,800 | SH | SOLE | 13,800 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 8,502 | 233,000 | SH | SOLE | 233,000 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 1,223 | 32,500 | SH | SOLE | 32,500 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 5,632 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
Amarin Corp Plc | SPONS ADR NEW | 023111206 | 2,841 | 137,000 | SH | SOLE | 137,000 | 0 | 0 | ||
GW Pharmaceuticals Plc | ADS | 36197T103 | 2,831 | 16,800 | SH | SOLE | 16,800 | 0 | 0 | ||
Abiomed Inc | COM | 003654100 | 3,341 | 11,700 | SH | SOLE | 11,700 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 7,220 | 269,000 | SH | SOLE | 269,000 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 1,396 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
Aerie Pharmaceuticals Inc | COM | 00771V108 | 7,178 | 151,117 | SH | SOLE | 151,117 | 0 | 0 | ||
Agios Pharmaceuticals Inc | COM | 00847X104 | 2,462 | 36,500 | SH | SOLE | 36,500 | 0 | 0 | ||
AKCEA THERAPEUTICS INC | COM | 00972L107 | 2,110 | 74,608 | SH | SOLE | 74,608 | 0 | 0 | ||
Alexion Pharmaceuticals Inc | COM | 015351109 | 9,952 | 73,641 | SH | SOLE | 73,641 | 0 | 0 | ||
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 3,160 | 33,800 | SH | SOLE | 33,800 | 0 | 0 | ||
Amgen Inc | COM | 031162100 | 4,558 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
Amicus Therapeutics Inc | COM | 03152W109 | 796 | 58,600 | SH | SOLE | 58,600 | 0 | 0 | ||
Arena Pharmaceuticals Inc | COM | 040047607 | 740 | 16,500 | SH | SOLE | 16,500 | 0 | 0 | ||
Array Biopharma Inc | COM | 04269X105 | 1,767 | 72,500 | SH | SOLE | 72,500 | 0 | 0 | ||
Biogen Inc | COM | 09062X103 | 2,245 | 9,500 | SH | SOLE | 9,500 | 0 | 0 | ||
Biomarin Pharmaceutical Inc | COM | 09061G101 | 5,704 | 64,284 | SH | SOLE | 64,284 | 0 | 0 | ||
Bluebird Bio Inc | COM | 09609G100 | 2,675 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
Celgene Corp | COM | 151020104 | 22,214 | 235,522 | SH | SOLE | 235,522 | 0 | 0 | ||
Dermira Inc | COM | 24983L104 | 407 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
Enanta Pharmaceuticals Inc | COM | 29251M106 | 5,827 | 61,000 | SH | SOLE | 61,000 | 0 | 0 | ||
Exelixis Inc | COM | 30161Q104 | 5,794 | 243,534 | SH | SOLE | 243,534 | 0 | 0 | ||
FibroGen Inc | COM | 31572Q808 | 1,071 | 19,700 | SH | SOLE | 19,700 | 0 | 0 | ||
G1 Therapeutics Inc | COM | 3621LQ109 | 1,631 | 98,482 | SH | SOLE | 98,482 | 0 | 0 | ||
Gilead Sciences Inc | COM | 375558103 | 18,094 | 278,284 | SH | SOLE | 278,284 | 0 | 0 | ||
Global Blood Therapeutics | COM | 37890U108 | 1,481 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | ||
Globus Med Inc | COM | 379577208 | 1,196 | 24,200 | SH | SOLE | 24,200 | 0 | 0 | ||
Halozyme Therapeutics Inc | COM | 40637H109 | 7,658 | 475,633 | SH | SOLE | 475,633 | 0 | 0 | ||
Horizon Pharma Plc | COM | G4617B105 | 3,382 | 128,000 | SH | SOLE | 128,000 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 7,799 | 25,100 | SH | SOLE | 25,100 | 0 | 0 | ||
Incyte Corp | COM | 45337C102 | 8,728 | 101,500 | SH | SOLE | 101,500 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 3,198 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
Intersect Ent Inc | COM | 46071F103 | 3,087 | 96,000 | SH | SOLE | 96,000 | 0 | 0 | ||
Ionis Pharmaceuticals Inc | COM | 462222100 | 3,877 | 47,781 | SH | SOLE | 47,781 | 0 | 0 | ||
Kalvista Pharmaceuticals Inc | COM | 483497103 | 6,062 | 213,061 | SH | SOLE | 213,061 | 0 | 0 | ||
Ligand Pharmaceuticals Inc | COM | 53220K504 | 918 | 7,300 | SH | SOLE | 7,300 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 342 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | ||
Millendo Therapeutics Inc | COM | 60040X103 | 925 | 61,860 | SH | SOLE | 61,860 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 1,590 | 21,700 | SH | SOLE | 21,700 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 792 | 54,580 | SH | SOLE | 54,580 | 0 | 0 | ||
Myokardia INC | COM | 62857M105 | 1,559 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
Myriad Genetics inc | COM | 62855J104 | 1,273 | 38,365 | SH | SOLE | 38,365 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 2,016 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Neurocrine Biosciences Inc | COM | 64125C109 | 9,128 | 103,600 | SH | SOLE | 103,600 | 0 | 0 | ||
PTC Therapuetics COM | COM | 69366J200 | 9,050 | 240,493 | SH | SOLE | 240,493 | 0 | 0 | ||
Radius Health Inc | COM | 750469207 | 2,109 | 105,829 | SH | SOLE | 105,829 | 0 | 0 | ||
Regeneron Pharmaceuticals | COM | 75886F107 | 12,985 | 31,630 | SH | SOLE | 31,630 | 0 | 0 | ||
Retrophin Inc | COM | 761299106 | 4,703 | 208,000 | SH | SOLE | 208,000 | 0 | 0 | ||
Sage Therapeutics Inc | COM | 78667J108 | 5,407 | 33,996 | SH | SOLE | 33,996 | 0 | 0 | ||
Sangamo Therapeutics Inc | COM | 800677106 | 457 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
Sarepta Therapeutics Inc | COM | 803607100 | 1,643 | 13,800 | SH | SOLE | 13,800 | 0 | 0 | ||
Seattle Genetics Inc | COM | 812578102 | 4,460 | 60,900 | SH | SOLE | 60,900 | 0 | 0 | ||
Stemline Therapeutics Inc | COM | 85858C107 | 10,232 | 796,245 | SH | SOLE | 796,245 | 0 | 0 | ||
Supernus Pharmaceuticals Inc | COM | 868459108 | 3,150 | 89,953 | SH | SOLE | 89,953 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 1,670 | 146,653 | SH | SOLE | 146,653 | 0 | 0 | ||
Tricida Inc | COM | 89610F101 | 751 | 19,066 | SH | SOLE | 19,066 | 0 | 0 | ||
Vertex Pharmaceuticals Inc | COM | 92532F100 | 9,400 | 51,122 | SH | SOLE | 51,122 | 0 | 0 | ||
Zogenix Inc | COM | 98978L204 | 5,114 | 93,000 | SH | SOLE | 93,000 | 0 | 0 |